Related Experiment Video
Updated: Jun 17, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Update on the sentinel lymph node procedure in vulvar cancer
Maaike H M Oonk1, Hedwig P van de Nieuwenhof, Ate G J van der Zee
1Department of Gynaecologic Oncology, University Medical Centre Groningen, Groningen, The Netherlands. m.h.m.oonk@og.umcg.nl
Expert Review of Anticancer Therapy
|December 18, 2009
Summary
The sentinel lymph node (SLN) procedure may allow for omitting inguinofemoral lymphadenectomy in early-stage vulvar cancer patients with a negative SLN, reducing treatment morbidity. This approach appears safe based on recent multicenter study evidence.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Pathology
Background:
- Standard treatment for early-stage vulvar cancer involves wide local excision and inguinofemoral lymphadenectomy, associated with significant morbidity.
- The sentinel lymph node (SLN) procedure offers a less invasive method to assess regional lymph node status.
Purpose of the Study:
- To review the various aspects of the sentinel lymph node (SLN) procedure in the context of vulvar cancer management.
- To evaluate the safety and efficacy of omitting inguinofemoral lymphadenectomy based on SLN status.
Main Methods:
- Review of recent multicenter observational studies providing level 3 evidence.
- Analysis of the sentinel lymph node (SLN) procedure's application in vulvar cancer.
Main Results:
- A large multicenter observational study suggests that omitting inguinofemoral lymphadenectomy is safe when the sentinel lymph node (SLN) is negative.
- The SLN procedure is a viable alternative to reduce treatment-related morbidity.
Conclusions:
- The sentinel lymph node (SLN) procedure is a key technique for staging vulvar cancer.
- Omitting inguinofemoral lymphadenectomy in cases of negative SLN status in vulvar cancer is supported by emerging evidence, potentially reducing patient morbidity.
